(Q61965710)
Statements
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Study to Evaluate the Efficacy and Safety of Tadalafil Once-a-day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia (English)
0 references
December 2011
0 references
October 2012
0 references
610
0 references
45 year
0 references